Marc Gailhardou is the new CEO of MSD Sweden and starting from this year he will be situated at MSD’s Swedish office in Hagastaden Stockholm.
Previously he has been a part of the European corporate group at Sanofi Pasteur MSD, responsible for ten countries.
“I am proud to continue to develop and grow SPMSD’s 20 years of success and I look forward to strengthen MSD’s leading position within vaccines and prevent infectious diseases,” says Marc Gailhardou.
Gailhardou holds a PhD in pharamcology from the University of Lyon and a Master in Health economy and Market Access from London Business School. His career at SPMSD started in 2013 and before that the worked at Sanofi as Senior Manager and Office manager. He has over 15 years of experience from the pharmaceutical industry and is an energetic and engaged leader with a number of successful business results in his portfolio.
